Hazlett, Burt & Watson’s Halozyme HALO Stock Holding History

Hazlett, Burt & Watson’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3K	Hold	40	–	–	﹤0.01%	812
2026 Q1	$3K	Buy	+40	New	+$2.82K	﹤0.01%	821

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Hazlett, Burt & Watson's HALO Position: Q2 2026 in Review

Hazlett, Burt & Watson held its Halozyme (HALO) position steady in Q2 2026 at 40 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Hazlett, Burt & Watson first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Hazlett, Burt & Watson held 40 shares of Halozyme worth $3K as of Q2 2026.
Hazlett, Burt & Watson left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #812 holding.
Hazlett, Burt & Watson first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.